← Open Payments lookup

NADYA PANJWANI: Open Payments

NPI 1538436571 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$862 in 21 payments from 10 companies in 2025. Trend: 2023 $265 · 2024 $563 · 2025 $862

Food & beverage: $687Education: $175
CompanyPaymentsAmount
Astellas Pharma US Inc5$269
SANOFI-AVENTIS U.S. LLC3$165
Janssen Biotech, Inc.3$96
Syndax Pharmaceuticals, Inc.2$64
SOBI, INC2$60
JAZZ PHARMACEUTICALS INC.1$60
Incyte Corporation2$57
Merck Sharp & Dohme LLC1$34
Takeda Pharmaceuticals U.S.A., Inc.1$33
Gamida Cell Inc.1$24

Products named: REZUROCK, DARZALEX, Vonjo, Cresemba, DEFITELIO, PREVYMIS, Xospata, LIVTENCITY.

Industry payments across TX — which companies pay providers there.